Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging
- PMID: 2052718
- DOI: 10.1148/radiology.180.1.2052718
Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging
Abstract
The influence of cirrhosis on superparamagnetic iron oxide (SPIO)-enhanced magnetic resonance (MR) imaging of the liver was studied in 31 rats. Experimental models included carbon tetrachloride-induced cirrhosis and liver engrafting of rhabdomyosarcoma S4T cells. Hepatic uptake of SPIO measured with relaxometry decreased dramatically with histologic grade, while splenic uptake increased; the same results were achieved by calculating K values. Imaging of 13 tumorous cirrhotic rats confirmed these results by showing a muted decrease in liver signal intensity on spin-echo images after injection of SPIO. Nevertheless, all intrahepatic tumors could be visualized, as confirmed by postmortem examination. On gradient-echo images, postinjection contrast between the tumor and the liver was not affected by cirrhosis. Thus, despite strong impairment of hepatic uptake in cirrhosis, the diagnostic efficacy of MR imaging with SPIO did not seem to be significantly affected.
Similar articles
-
Development of hepatomas in hyperplastic nodules induced in the rat liver: detection with superparamagnetic iron oxide-enhanced magnetic resonance imaging.Acad Radiol. 1996 Apr;3(4):330-5. doi: 10.1016/s1076-6332(96)80253-4. Acad Radiol. 1996. PMID: 8796683
-
Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function.Radiology. 2002 Mar;222(3):661-6. doi: 10.1148/radiol.2223010690. Radiology. 2002. PMID: 11867782
-
Evaluation of superparamagnetic iron oxide for MR imaging of liver injury: proton relaxation mechanisms and optimal MR imaging parameters.Magn Reson Med Sci. 2006 Jul;5(2):89-98. doi: 10.2463/mrms.5.89. Magn Reson Med Sci. 2006. PMID: 17008765
-
In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver.Radiology. 2004 Dec;233(3):781-9. doi: 10.1148/radiol.2333031714. Epub 2004 Oct 14. Radiology. 2004. PMID: 15486216
-
MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.AJR Am J Roentgenol. 1993 Dec;161(6):1191-8. doi: 10.2214/ajr.161.6.8249724. AJR Am J Roentgenol. 1993. PMID: 8249724
Cited by
-
Correlation of Kupffer cell function and hepatocyte function in chronic viral hepatitis evaluated with superparamagnetic iron oxide-enhanced magnetic resonance imaging and scintigraphy using technetium-99m-labelled galactosyl human serum albumin.Exp Ther Med. 2011 Jul;2(4):607-613. doi: 10.3892/etm.2011.255. Epub 2011 Apr 11. Exp Ther Med. 2011. PMID: 22977548 Free PMC article.
-
Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media.Eur Radiol. 2007 Oct;17(10):2519-30. doi: 10.1007/s00330-007-0602-5. Epub 2007 Feb 16. Eur Radiol. 2007. PMID: 17429640 Review.
-
Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging.Eur Radiol. 2005 Jan;15(1):140-7. doi: 10.1007/s00330-004-2508-9. Epub 2004 Sep 22. Eur Radiol. 2005. PMID: 15449000
-
MDCT and superparamagnetic iron oxide (SPIO)-enhanced MR findings of intrapancreatic accessory spleen in seven patients.Eur Radiol. 2006 Sep;16(9):1887-97. doi: 10.1007/s00330-006-0193-6. Epub 2006 Mar 18. Eur Radiol. 2006. PMID: 16547707
-
Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma.Br J Cancer. 2005 Jul 11;93(1):131-6. doi: 10.1038/sj.bjc.6602668. Br J Cancer. 2005. PMID: 15970924 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical